ACTA1 and neoplasm: Non-specific ablation of myoCAFs (e.g., αSMA+ depletion or Sonic hedgehog inhibition) not only fails to restore immune infiltration but accelerates tumor progression (44–47) likely due to inadvertent disruption of tumor-restraining CAF subsets within the population (Figure 2) (48, 49).